HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Rehan Azeem Selected Research

Type 2 Diabetes Mellitus (MODY)

1/2018Efficacy and Safety of ITCA 650, a Novel Drug-Device GLP-1 Receptor Agonist, in Type 2 Diabetes Uncontrolled With Oral Antidiabetes Drugs: The FREEDOM-1 Trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Rehan Azeem Research Topics

Disease

2Gout
08/2023 - 07/2023
1Infections
07/2023
1Stomatitis
07/2023
1Type 2 Diabetes Mellitus (MODY)
01/2018
1Body Weight (Weight, Body)
01/2018

Drug/Important Bio-Agent (IBA)

2Uric Acid (Urate)IBA
08/2023 - 07/2023
1Urate Oxidase (Uricase)IBA
08/2023
1Sirolimus (Rapamycin)FDA Link
07/2023
1PegloticaseFDA Link
07/2023
1Glucagon-Like Peptide-1 ReceptorIBA
01/2018
1Exenatide (Byetta)FDA Link
01/2018